| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/24/1997 | WO1997048411A1 Medicinal compositions for treating liver diseases |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997048408A2 Method for the prevention and treatment of mastitis |
| 12/24/1997 | WO1997048407A1 Substances for treating leptin pathway abnormalities |
| 12/24/1997 | WO1997048400A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048399A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048381A1 Pharmaceutical preparation in the form of liposomes |
| 12/24/1997 | WO1997048379A1 Nasal administration of desmopressin |
| 12/24/1997 | WO1997048370A2 Vaccines comprising synthetic genes |
| 12/24/1997 | WO1997048275A1 Endoderm, cardiac and neural inducing factors |
| 12/24/1997 | WO1997044456A3 Tumor virus susceptibility genes and gene products, and uses related thereto |
| 12/24/1997 | WO1997044059A3 Cartilage type ii collagen as an angiogenic factor |
| 12/24/1997 | WO1997043404A3 Ribozyme variants with improved catalytic activity under low magnesium conditions |
| 12/24/1997 | WO1997043314A3 Collagen binding protein compositions and methods of use |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997039122A3 Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/24/1997 | CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168694A Polypeptide with reduced allergenicity |
| 12/24/1997 | CN1168679A Monoclonal antibody fragments having immunosuppressant activity |
| 12/24/1997 | CN1168678A Method of treating diabetes mellitus using KGF |
| 12/24/1997 | CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases |
| 12/24/1997 | CN1168675A New compound |
| 12/24/1997 | CN1168673A New dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals |
| 12/24/1997 | CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof |
| 12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
| 12/24/1997 | CN1168413A Erythropoietin |
| 12/24/1997 | CA2294433A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | CA2259122A1 Novel ptp-20, pcp-2, bdp1, clk and sirp proteins and related products and methods |
| 12/24/1997 | CA2258789A1 Endoderm, cardiac and neural inducing factors |
| 12/24/1997 | CA2258589A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258587A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258573A1 Hodgkin's disease associated molecules and uses thereof |
| 12/24/1997 | CA2258568A1 Vaccines comprising synthetic genes |
| 12/24/1997 | CA2258552A1 Nasal administration of desmopressin |
| 12/24/1997 | CA2258526A1 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 12/24/1997 | CA2258515A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | CA2258507A1 Chemokine beta-15 |
| 12/24/1997 | CA2258504A1 Gene therapy for obesity |
| 12/24/1997 | CA2258099A1 Insulin preparations containing carbohydrates |
| 12/24/1997 | CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof |
| 12/24/1997 | CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | CA2257842A1 Polynucleotides encoding secreted proteins from human pbmc |
| 12/24/1997 | CA2257834A1 Polynucleotides encoding secreted proteins |
| 12/24/1997 | CA2257827A1 Polynucleotide encoding secreted protein isolated from human dendritic cells |
| 12/24/1997 | CA2257528A1 Human protein kinase c inhibitor homolog |
| 12/24/1997 | CA2257130A1 Human camp-dependent protein kinase inhibitor homolog |
| 12/24/1997 | CA2253285A1 Pharmaceutical preparation in the form of liposomes |
| 12/24/1997 | CA2251779A1 Method for the prevention and treatment of mastitis |
| 12/24/1997 | CA2246751A1 Human metabotropic glutamate receptor |
| 12/23/1997 | US5700928 Polynucleotide encoding saliva binding protein |
| 12/23/1997 | US5700927 Tbc1 gene and uses thereof |
| 12/23/1997 | US5700924 Serpin derived from human hypothalamus |
| 12/23/1997 | US5700923 Rigid linker comprising at least one non-nucleotidic unit, flanked by first and second flanking regions of at least four contiguous, covalently-linked nucleotides; complementary to target region on substrate rna molecule |
| 12/23/1997 | US5700922 PNA-DNA-PNA chimeric macromolecules |
| 12/23/1997 | US5700915 Human interleukin immunopurification processes |
| 12/23/1997 | US5700914 Preventing activation(and degradation) of blood coagulation factor vii(in solution) during repeated chromatography cycles with zinc ions present in the solution |
| 12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
| 12/23/1997 | US5700910 N-acyl-S-(2-hydroxyalkyl) cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccines |
| 12/23/1997 | US5700909 For stimulating neural cell outgrowth |
| 12/23/1997 | US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 12/23/1997 | US5700905 Hexapeptides, cyclic peptides; as binding g-protein-linked receptors |
| 12/23/1997 | US5700830 Prevention adhesion of cancerous cells and noncancerous structures in mammals |
| 12/23/1997 | US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 12/23/1997 | US5700800 Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound |
| 12/23/1997 | US5700795 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of type II diabetes |
| 12/23/1997 | US5700783 Method of treating urinary incontinence |
| 12/23/1997 | US5700782 Liquid comprising protein, fat having specified fatty acid profile, carbohydrate, dietary fiber, folic acid, beta-carotene, carnitine, taurine |
| 12/23/1997 | US5700781 Administering human chorionic gonadotropin |
| 12/23/1997 | US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor |
| 12/23/1997 | US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines |
| 12/23/1997 | US5700778 Inhibit synaptic transmission |
| 12/23/1997 | US5700777 Fatty acid - pulmonary surfactant conjugates |
| 12/23/1997 | US5700776 Medicaments comprising glicentin as active ingredient |
| 12/23/1997 | US5700775 Method and treatment composition for decreasing patient time in catabolic state after traumatic injury |
| 12/23/1997 | US5700774 Treatment of bone disorders |
| 12/23/1997 | US5700690 Vector comprising fibroblast specific gene promoter sequence linked to dna sequence of interest |
| 12/23/1997 | US5700683 Virulence-attenuating genetic deletions deleted from mycobacterium BCG |
| 12/23/1997 | US5700677 Protein analogues of tissue plasminogen activator |
| 12/23/1997 | US5700675 Protein kinase required for Ras signal transduction |
| 12/23/1997 | US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system |
| 12/23/1997 | US5700663 Modified at one or more potential glycosylation sites or at the arginine 393 position |
| 12/23/1997 | US5700662 Culturing a genetic engineered host cell, gene expressing a dna, encoding a proinsulin, enzymatically disconnecting |
| 12/23/1997 | US5700658 Purified, isolated polynucleotide coding for intercellular adhesion molecule protein |
| 12/23/1997 | US5700649 Method of detection of urinary tumor associated antigen |
| 12/23/1997 | US5700638 Cell death regulator |
| 12/23/1997 | US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use |
| 12/23/1997 | US5700486 Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions |
| 12/23/1997 | US5700466 Culture product from hybridoma cell |
| 12/23/1997 | US5700465 Administering immunoglobulin which reacts with receptors and stimulates neutrophil function in host animal cell |
| 12/23/1997 | US5700461 Method for inhibiting HIV replication using IL-4 |
| 12/23/1997 | US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor |
| 12/23/1997 | US5700447 Methods and materials for the diagnosis and treatment of conditions such as stroke |
| 12/23/1997 | US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases |
| 12/23/1997 | US5700354 High strength, tensile strength |
| 12/23/1997 | US5700353 Paper strengthened with solubilized collagen and method |
| 12/23/1997 | CA2084663C Non-hygroscopic mono-ammonium salts |
| 12/23/1997 | CA1339596C Viral expression inhibitors |